ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för desirudin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar

Bibliografisk träff 2021-03-28

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.

Colarossi G, Maffulli N, Trivellas A, Schnöring H, Hatam N, Tingart M, Migliorini F.

Int J Clin Pharm · review-article; review; network meta-analysis; journal article · DOI 10.1007/s11096-021-01260-z

Bibliografisk träff 2014-11-01

Safety of desirudin in thrombosis prevention after total knee arthroplasty: the DESIR-ABLE study.

Jove M, Maslanka M, Minkowitz HS, Jaffer AK, DESIR-ABLE Investigators.

Am J Ther · clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1097/mjt.0b013e3182691778

Bibliografisk träff 2012-08-01

Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.

Shorr AF, Eriksson BI, Jaffer AK, Smith J.

J Thromb Haemost · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1538-7836.2012.04803.x

Bibliografisk träff 2011-09-01

Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis.

Graetz TJ, Tellor BR, Smith JR, Avidan MS.

Expert Rev Cardiovasc Ther · comparative study; review; journal article · DOI 10.1586/erc.11.131

Bibliografisk träff 2011-06-01

Looking back into the future: desirudin in acute coronary syndromes and coronary stenting.

Vranckx P, Valgimigli M, Serruys P.

EuroIntervention · review; journal article · DOI 10.4244/eijv7i2a42

Bibliografisk träff 2010-11-01

Desirudin (Iprivask) for DVT prevention.

Författaruppgift saknas

Med Lett Drugs Ther · journal article

Bibliografisk träff 2009-11-13

Desirudin dosing and monitoring in moderate renal impairment.

Nafziger AN, Bertino JS.

J Clin Pharmacol · journal article · DOI 10.1177/0091270009350626

Bibliografisk träff 2002-01-01

[Desirudin (Revasc) to prevent thromboembolic complications after hip or knee replacement surgery].

Heiz-Valle C, de Maistre E, Commun N, Heck M, Lecompte T, Hoffman M.

Therapie · clinical trial; journal article

Bibliografisk träff 1999-11-01

[Desirudine (Revasc): preventive therapy for deep venous thrombosis].

Andréjak M.

Presse Med · comparative study; journal article

Bibliografisk träff 1996-06-01

Hirudin CGP 39393 as thromboprophylaxis.

Williams DJ, Mahomed A.

Lancet · letter; comment · DOI 10.1016/s0140-6736(96)90718-7

Bibliografisk träff 1996-03-01

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.

Eriksson BI, Ekman S, Kalebo P, Zachrisson B, Bach D, Close P.

Lancet · comparative study; clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.1016/s0140-6736(96)91200-3

Bibliografisk träff 1995-01-01

Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393).

Thürmann P, Harder S, Kirchmaier CM.

Eur J Clin Pharmacol · clinical trial; randomized controlled trial; journal article · DOI 10.1007/bf00198305

Bibliografisk träff 1994-12-01

Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog model.

Walenga JM, Koza MJ, Park SJ, Terrell MR, Pifarré R.

Ann Thorac Surg · journal article · DOI 10.1016/0003-4975(94)91661-6

Bibliografisk träff 1994-11-01

Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).

Close P, Bichler J, Kerry R, Ekman S, Bueller HR, Kienast J, Marbet GA, Schramm W, Verstraete M.

Coron Artery Dis · clinical trial; research support, non-u.s. gov't; journal article

Bibliografisk träff 1994-08-01

Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.

Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P.

Thromb Haemost · clinical trial; journal article · DOI 10.1055/s-0038-1648844

Bibliografisk träff 1993-10-01

Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.

Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P.

J Am Coll Cardiol · journal article · DOI 10.1016/0735-1097(93)90419-2

Bibliografisk träff 1993-09-01

Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers.

Marbet GA, Verstraete M, Kienast J, Graf P, Hoet B, Tsakiris DA, Silling-Engelhardt G, Close P.

J Cardiovasc Pharmacol · clinical trial; multicenter study; journal article · DOI 10.1097/00005344-199309000-00004

Bibliografisk träff 1993-06-01

Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat.

Butler KD, Dolan SL, Talbot MD, Wallis RB.

Blood Coagul Fibrinolysis · journal article · DOI 10.1097/00001721-199306000-00011

Bibliografisk träff 1991-04-01

Experimental studies on a recombinant hirudin, CGP 39393.

Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.

Thromb Haemost · comparative study; journal article · DOI 10.1055/s-0038-1648151

Bibliografisk träff 1991-03-01

The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.

Peters RF, Lees CM, Mitchell KA, Tweed MF, Talbot MD, Wallis RB.

Thromb Haemost · journal article

Bibliografisk träff 1990-11-01

The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.

Lindhout T, Blezer R, Hemker HC.

Thromb Haemost · journal article · DOI 10.1055/s-0038-1647337

Bibliografisk träff 1990-04-01

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.

Agnelli G, Pascucci C, Cosmi B, Nenci GG.

Thromb Haemost · comparative study; journal article · DOI 10.1055/s-0038-1645195

Bibliografisk träff 1989-07-01

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.

Talbot M.

Semin Thromb Hemost · review; journal article · DOI 10.1055/s-2007-1002722

Bibliografisk träff 1989-02-01

Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo.

Talbot MD, Ambler J, Butler KD, Findlay VS, Mitchell KA, Peters RF, Tweed MF, Wallis RB.

Thromb Haemost · journal article · DOI 10.1055/s-0038-1646530